A study performed by Ellison-Zelski et al. previously determined that SIN3a is expressed in breast cancer cells, and they further expanded their studies to conclude that SIN3a is a regulator of the gene expression, growth, and survival of estrogen receptor alpha-positive breast cancer cells [56]. This evidence concerns the gene ESR1 and breast carcinoma.